Evidence map›Paper›PMID 39100838›Full record

ArticleTranslational andrology and urology2024

Diagnostic value of oxidation-reduction potential for male infertility: a systematic review and meta-analysis.

Yangyang Tan, Yacheng Yuan, Xukai Yang, Yong Wang, Linhai Liu

Abstract read
In one paragraph

Article in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yangyang Tan *Department of Urology, The Second People's Hospital of Neijiang, Neijiang, China.
Yacheng Yuan *The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, China.
Xukai YangThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, China.
Yong WangDepartment of Urology, The Second People's Hospital of Neijiang, Neijiang, China.
Linhai LiuDepartment of Urology, The Second People's Hospital of Neijiang, Neijiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the last few years, studies have initially confirmed the diagnostic significance of oxidation-reduction potential (ORP) in male infertility patients. In this article, we used meta-analysis to clarify the role of ORP in the diagnosis of male infertility. Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched by computer for relevant published literature. Quality assessment of the included literature was performed by Quality Assessment of Diagnostic Accuracy Studies (QUADAS) scale. Heterogeneity analysis of included studies was conducted using Metadisc 1.4 and Stata 12.0, and effective models for quantitative synthesis were selected based on heterogeneity results; the sensitivity and specificity of the synthesis were obtained using the software, and in order to reduce the effects of heterogeneity and thresholds, the information of sensitivity and specificity was integrated. We used the subject receiver operating characteristic (SROC) curve, area under the curve (AUC) and Q* index for comprehensive evaluation. Results: Seven papers were eventually included in the study, and the results showed that ORP had a sensitivity of 0.81 [95% confidence interval (CI): 0.80-0.82] and specificity of 0.66 (95% CI: 0.63-0.69), an AUC of 0.8 and a Q* index of 0.74 for the diagnosis of male infertility. Conclusions: ORP has high sensitivity and specificity for diagnosing male infertility.

Indexed as

diagnosisMale infertilitymeta-analysisMiOXSYSoxidation-reduction potential (ORP)

Identifiers

PMID39100838
PMCPMC11291403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.